SCHEMBL6650163

SCHEMBL6650163

CN(C)CCCn1ccnc1Cc1ccc(Cl)cc1CO

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSEN1 P49768 1/20 0.38
PSEN2 P49810 1/20 0.38
APH1B Q8WW43 1/20 0.38
NCSTN Q92542 1/20 0.38
APH1A Q96BI3 1/20 0.38
PSENEN Q9NZ42 1/20 0.38
CYP1A2 P05177 4/20 0.37
CYP2D6 P10635 4/20 0.37
KMT2A Q03164 4/20 0.37
TP53 P04637 3/20 0.37
CYP3A4 P08684 3/20 0.37
HTR1A P08908 3/20 0.37
DRD2 P14416 3/20 0.37
CYP2C19 P33261 3/20 0.37
MEN1 O00255 3/20 0.37
LMNA P02545 3/20 0.37
MAPT P10636 3/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
SLC6A4 P31645 3/20 0.37
ADRA1A P35348 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6648269 0.87 KMT2A (0.46) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL6650687 0.79 KMT2A (0.47) CYP2D6KMT2ATP53CYP3A4CYP2C19
SCHEMBL6650633 0.78 ALDH1A1 (0.38) CYP1A2KMT2ACYP3A4CYP2C19MEN1
SCHEMBL6654380 0.77 HSP90AA1 (0.55) CYP1A2CYP2D6KMT2ACYP3A4CYP2C19
SCHEMBL6649429 0.77 KCNH2 (0.41) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL6648442 0.74 HRH3 (0.39) SLC6A4HRH1KCNH2CHRM2CHRM4
SCHEMBL6651569 0.73 KMT2A (0.47) CYP2D6KMT2ATP53CYP2C19MEN1
SCHEMBL5705441 0.73 HSP90AA1 (0.36) CYP2D6KMT2ACYP3A4CYP2C19MEN1
SCHEMBL6654159 0.73 TRPM5 (0.40) CYP1A2CYP2D6KMT2ATP53CYP3A4
SCHEMBL6654254 0.73 TRPM5 (0.37) CYP1A2CYP2D6KMT2ATP53CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1103243-B1 UTILIZATION OF ARYL(OR HETEROARYL)AZOLYLCARBINOL DERIVATIVES FOR THE TREATMENT OF TROUBLES MEDIATED BY AN EXCESS OF SUBSTANCE P ESTEVE LABOR DR (ES) 2004-01-07 EP claimed